Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.

Abstract:

:The histoculture drug sensitivity assay (HDRA) has been demonstrated to have high predictability for resistance, sensitivity, and survival for gastrointestinal cancer (Clin Cancer Res 1: 305-311, 1995; Clin Cancer Res 1: 1537-1543, 1995). In this report, we evaluated the clinical usefulness of the HDRA in ovarian cancer. HDRA was performed on tumors from patients with ovarian cancer. Eighty-five cases (97%) were evaluable. Tumor fragments were cultured on collagen-sponge gels. The cultures were incubated with cisplatin (CDDP) for seven days. Cell viability were assessed with the MTT end point. The optimal cut off concentration of CDDP was determined to be 25 micrograms/ml by correlation with the historical clinical response rate to CDDP. HDRA results were correlated to clinical response of 15 patients who received CDDP-based therapy that included doxorubicin and cyclophosphamide (CAP therapy). The true positive rate was 88%, the true negative rate was 86%, the sensitivity was 88%, the specificity was 86%, and the accurate prediction rate was 87% when HDRA results were compared to the response of the treated patients. The data suggest that the HDRA is capable of predicting the response to antitumor chemotherapy in patients with ovarian cancer and that measuring response to CDDP can be useful for optimization of CAP chemotherapy for patients with this disease.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Ohie S,Udagawa Y,Kozu A,Komuro Y,Aoki D,Nozawa S,Moossa AR,Hoffman RM

subject

Has Abstract

pub_date

2000-05-01 00:00:00

pages

2049-54

issue

3B

eissn

0250-7005

issn

1791-7530

journal_volume

20

pub_type

杂志文章
  • Small cell carcinoma of the colon arising in a carcinoid tumor.

    abstract::Small cell carcinomas of the gastrointestinal tract are rare and clinically aggressive tumors. A case is presented of a 70 year-old woman who presented with small bowel obstruction and was found to have a cecal mass. She underwent right hemicolectomy, and histopathology showed a small cell carcinoma arising in the bac...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Saif MW

    更新日期:2013-04-01 00:00:00

  • The Tumor Suppressor MicroRNA-1 Exhibits Restricted Inhibition of Proliferation of Ovarian Cancer Cells.

    abstract:BACKGROUND:MicroRNAs are able to control vital tumor biological processes, such as proliferation, tissue transformation and cell migration, as well as apoptosis. One of the micro RNAs, namely miR-1, has been classified as a tumor suppressor, however, preliminary data did not confirm this finding in ovarian cancer (OC) ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Stope MB,Hettenbach D,Kaul A,Paditz M,Diesing K,Burchardt M,Zygmunt M,Mustea A,Koensgen D

    更新日期:2016-07-01 00:00:00

  • The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study.

    abstract::Glutathione (GSH) concentration is high in most tumour cells and this may be an important factor in resistance to chemotherapy. Previous in-vitro and animal experiments have shown a differential response of tumour versus normal cells to various cysteine delivery systems. More specifically, an in-vitro assay showed tha...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Kennedy RS,Konok GP,Bounous G,Baruchel S,Lee TD

    更新日期:1995-11-01 00:00:00

  • Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas.

    abstract::Most patients with musculoskeletal sarcoma do not recover satisfactory limb function after limb salvage surgery. To achieve satisfactory improvement of limb function, we developed a unique surgical modality of photodynamic therapy using acridine orange (AO-PDT) and clinically applied it to patients with musculoskeleta...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Kusuzaki K,Murata H,Matsubara T,Miyazaki S,Okamura A,Seto M,Matsumine A,Hosoi H,Sugimoto T,Uchida A

    更新日期:2005-03-01 00:00:00

  • Prediction of Response to Stereotactic Radiosurgery for Brain Metastases Using Convolutional Neural Networks.

    abstract:BACKGROUND:It is unclear whether radiomic phenotypes of brain metastases (BM) are related to radiation therapy prognosis. This study assessed whether a convolutional neural network (CNN)-based radiomics model which learned computer tomography (CT) image features with minimal preprocessing, could predict early response ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12875

    authors: Cha YJ,Jang WI,Kim MS,Yoo HJ,Paik EK,Jeong HK,Youn SM

    更新日期:2018-09-01 00:00:00

  • Glycerophosphoinositols as potential markers of ras-induced transformation and novel second messengers.

    abstract::Glycerophosphoinositols are metabolites formed by the sequential action of a phospholipase A2 specific for membrane phosphoinositides, and a lysolipase. Increased levels of these compounds characterize cell lines of different origin transformed by ras and other oncogenes. Thus, glycerophosphoinositols have been propos...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Corda D,Falasca M

    更新日期:1996-05-01 00:00:00

  • Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.

    abstract::22 patients with advanced non-small-cell lung cancer were randomized to receive chemotherapy (ifosfamide) or chemotherapy followed by thymosin alpha1 + low-dose IFNalpha. Chemo-immunotherapy induced an enhanced response rate compared with chemotherapy alone (33% and 10% respectively). Although these differences were n...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Salvati F,Rasi G,Portalone L,Antilli A,Garaci E

    更新日期:1996-03-01 00:00:00

  • The effects of cytosine arabinoside and GM-CSF in leukemic cells in vitro.

    abstract::An in vitro pilot study was conducted of the possible utility of combining low doses of cytosine arabinoside (araC) and GM-CSF to stimulate leukemic cell differentiation. Cytosine arabinoside induced macrophage differentiation in some cultures but only when the drug produced substantial cytostatic effects. GM-CSF, whe...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gao XZ,Yin MY,Preisler HD

    更新日期:1989-07-01 00:00:00

  • Immunoluminescent detection of intercellular adhesion molecule-1 and aminopeptidase N on human melanoma cells.

    abstract:BACKGROUND:During the complex process of melanoma cell detachment from the primary tumor and subsequent metastasis, different cell surface proteins are involved in tumor cell interactions with extracellular matrix (ECM) components and surrounding cells. Melanoma cells are able to vary their expression patterns of adhes...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Laube F

    更新日期:2007-07-01 00:00:00

  • The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.

    abstract:BACKGROUND:Deregulated RAS/RAF/MAPK and PI3K/AKT/mTOR signaling pathways are found in hepatocellular carcinoma (HCC). This study aimed to test the inhibitory effects of PI-103 (a small molecule inhibitor of PI3K and mTOR) and sorafenib as single agents and in combination on HCC tumorigenesis in an in vivo xenograft mod...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gedaly R,Angulo P,Chen C,Creasy KT,Spear BT,Hundley J,Daily MF,Shah M,Evers BM

    更新日期:2012-07-01 00:00:00

  • Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.

    abstract:BACKGROUND:The cisplatin-pemetrexed and cisplatin-gemcitabine combinations are considered the standard treatment for malignant pleural mesothelioma. The purpose of this study was to examine the efficacy of gemcitabine plus docetaxel in the first-line setting, as this combination has not been investigated in mesotheliom...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ralli M,Tourkantonis I,Makrilia N,Gkini E,Kotteas E,Gkiozos I,Katirtzoglou N,Syrigos K

    更新日期:2009-08-01 00:00:00

  • A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.

    abstract::We herein report a case of locally advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer that achieved a pathological complete response (pCR) with pertuzumab, trastuzumab and docetaxel therapy. A 70-year-old female presented with an elastic hard mass, 5.0 cm in diameter with broad redness and...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11530

    authors: Inoue Y,Yamashita N,Tokunaga E,Tanaka K,Ueo H,Saeki H,Oki E,Yamamoto H,Maehara Y

    更新日期:2017-04-01 00:00:00

  • 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.

    abstract:UNLABELLED:The aim this study was to assess the efficacy of cisplatin-epirubicin-vinorelbine, as primary chemotherapy, in reducing the tumour burden in T2-3 N0-2 breast carcinomas. Breast conservative surgery (BCS) rate, clinical and pathological complete response (pCR), toxicity and 5-year disease-free survival (DFS) ...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Barni S,Visini M,Piazza E,Ionta MT,Ardizzoia A,Arnoldi E,Fava S,Pinotti G,Torretta F,Corradini G,Villa S,Nosenzo AM,Massidda B,Cazzaniga ME

    更新日期:2007-07-01 00:00:00

  • A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients.

    abstract:BACKGROUND/AIM:Elderly patients represent an important subgroup of patients with brain metastases. A survival score has been developed specifically for these patients. PATIENTS AND METHODS:A total of 544 elderly patients (aged ≥65 years) receiving whole-brain radiotherapy alone were divided into a test (n=272) and a v...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Evers JN,Schild SE,Segedin B,Nagy V,Khoa MT,Trang NT,Rades D

    更新日期:2014-05-01 00:00:00

  • Comparative immunological analysis of innate immunity activation after oral administration of wheat fermented extract to teleost fish.

    abstract:BACKGROUND:Intradermal or oral administration of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) has shown prophylactic and antitumor effects without serious side-effects. While it is known that tumor necrosis factor (TNF)-alpha produced by activated macrophages plays an important role in the expression me...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kadowaki T,Yasui Y,Takahashi Y,Kohchi C,Soma G,Inagawa H

    更新日期:2009-11-01 00:00:00

  • Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.

    abstract:BACKGROUND:Dehydroepiandrosterone (DHEA) and its analogs have potent chemoprotective actions in mouse skin tumorigenesis models. To assess this association in humans, we investigated the relationship of prediagnostic serum concentrations of DHEA and dehydroepiandrosterone sulfate (DHEAS) to the subsequent risk of devel...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Alberg AJ,Gordon GB,Genkinger JM,Hoffman SC,Selvin E,Comstock GW,Helzlsouer KJ

    更新日期:2001-11-01 00:00:00

  • Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways.

    abstract:BACKGROUND/AIM:The aim of this study is to find synergistic effect using FH535 and sorafenib by targeting the RAS/RAF/MAPK and WNT/β-catenin pathways. MATERIALS AND METHODS:3H-Thymidine incorporation assays were performed to address Huh7 and liver cancer stem cell (LCSC) inhibition using FH535 and sorafenib, alone and...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Galuppo R,Maynard E,Shah M,Daily MF,Chen C,Spear BT,Gedaly R

    更新日期:2014-04-01 00:00:00

  • Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.

    abstract::Aromatase inhibitors (AIs) are important therapeutic drugs for postmenopausal women with hormone receptor-positive breast cancer. However, adverse effects of AIs such as arthralgia have been extensively reported. We performed a joint prospective, multi-institutional investigation to find out whether a low-dose and sho...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Kubo M,Onishi H,Kuroki S,Okido M,Shimada K,Yokohata K,Umeda S,Ogawa T,Tanaka M,Katano M

    更新日期:2012-06-01 00:00:00

  • A study of serum biomarkers associated with relapse of cervical cancer.

    abstract:BACKGROUND/AIM:To discover candidate protein biomarkers in the serum of patients with cervical cancer that differentiate between patients with relapse from those who are tumor-free after primary treatment with (platinum-based chemo-) radiation. PATIENTS AND METHODS:Surface-enhanced laser desorption/ionization time-of-...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Mordhorst LB,Sorbe B,Ahlin C

    更新日期:2012-11-01 00:00:00

  • Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.

    abstract:BACKGROUND:Recombinant human interleukin-2 (IL-2) has a well-documented anti-tumor activity against RCC and has demonstrated a synergistic anti-tumor activity between doxorubicin and IL-2, thus providing better survival. This study investigated the toxicity and efficacy of the association between doxorubicin and IL-2, ...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Naglieri E,Gebbia V,Durini E,Lelli G,Abbate I,Selvaggi FP,Di Tonno P,Colucci G

    更新日期:1998-05-01 00:00:00

  • Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer.

    abstract:BACKGROUND/AIM:The presence of ascites in ovarian cancer patients is considered a negative prognostic factor. The underlying mechanisms are not clearly understood. MATERIALS AND METHODS:The amount of ascites was evaluated, preferably, using diffusion-weighted MRI at primary diagnosis in a retrospective cohort of 214 w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13800

    authors: Coosemans AN,Baert T,D'Heygere V,Wouters R,DE Laet L,VAN Hoylandt A,Thirion G,Ceusters J,Laenen A,Vandecaveye V,Vergote I

    更新日期:2019-11-01 00:00:00

  • Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.

    abstract::The chemopreventive efficacies of the retinoid all-trans-N-(4-hydroxyphenyl)-retinamide (4-HPR) and the anti-estrogen tamoxifen citrate were evaluated against N-methyl-N'-nitrosourea (MNU) induced mammary cancer in 120-day old female Sprague-Dawley rats. The agents were tested alone and in combination. They were admin...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Moon RC,Kelloff GJ,Detrisac CJ,Steele VE,Thomas CF,Sigman CC

    更新日期:1992-07-01 00:00:00

  • Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.

    abstract::The high glucose consumption of tumour cells has been well known since Warburg's investigations. Nevertheless, the reason for this phenomenon is still a matter of speculation. Glucose uptake of tumour cells is mainly mediated by GLUT1. In this study, the question of whether glucose uptake as well as expression of GLUT...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hauptmann S,Grünewald V,Molls D,Schmitt WD,Köbel M,Kriese K,Schürmann A

    更新日期:2005-09-01 00:00:00

  • Is weekly docetaxel an active and gentle chemotherapy in the treatment of metastatic breast cancer?

    abstract:BACKGROUND:Docetaxel is a very active drug against breast cancer, but at the standard dose causes severe myelosuppression. In order to reduce the toxicity while maintaining the activity, weekly docetaxel administration was tested. PATIENTS AND METHODS:We enrolled 30 patients with metastatic breast cancer, who had been...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Maisano R,Mare M,Zavettieri M,Caristi N,Mesiti M,Scisca C,La Torre F

    更新日期:2003-03-01 00:00:00

  • Fluorescence Imaging of Actin Fine Structure in Tumor Tissues Using SiR-Actin Staining.

    abstract:BACKGROUND:The rearrangement of actin cytoskeleton is being increasingly considered a marker of cancer cell activity, but the fine structure and remodeling of microfilaments within tumor tissue still remains unclear. MATERIALS AND METHODS:We used the recently introduced silicon-rhodamine (SiR)-actin dye to visualize e...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11100

    authors: Klementieva NV,Snopova LB,Prodanets NN,Furman OE,Dudenkova VV,Zagaynova EV,Lukyanov KA,Mishin AS

    更新日期:2016-10-01 00:00:00

  • Association of protease activity against IGFBP-3 with peritoneal fluid mitogens: possible implications for the ectopic growth of endometrial cells in women with endometriosis.

    abstract:BACKGROUND:Recent data indicate the implication of an IGF/IGFBP/protease system in the development of ectopic implants of endometrium (endometriosis) in the pelvic cavity. MATERIAL AND METHODS:We characterized mitogens and protease(s) against IGFBP-3 in the peritoneal fluid of women with or without endometriosis using...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Koutsilieris M,Lavergne E,Lemay A

    更新日期:1997-03-01 00:00:00

  • Determining Patient Satisfaction and Treatment Desires in Patients With Musculoskeletal Sarcoma of the Knee After Joint-preservation Surgery Using a Questionnaire Survey.

    abstract:BACKGROUND/AIM:For cases of musculoskeletal sarcoma of the knee presenting to our institute, we prioritize joint preservation whenever possible. To investigate patient satisfaction and desire for joint preservation, a questionnaire survey was performed. PATIENTS AND METHODS:Surveys were mailed to 62 patients with musc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13307

    authors: Abe K,Yamamoto N,Hayashi K,Takeuchi A,Kato S,Miwa S,Igarashi K,Inatani H,Aoki YU,Higuchi T,Taniguchi Y,Tsuchiya H

    更新日期:2019-04-01 00:00:00

  • Antiproliferative activity of vitamin D compounds in combination with cytostatics.

    abstract::Calcitriol is a potent antiproliferative agent against various tumour cells in vitro. Here, the results of a study on vitamin D compounds (calcitriol's analogues PRI-1906 and PRI-2191) as potential agents in combined antitumour therapy in vitro are presented. Applying antiproliferative SRB and MTT assays, the growth i...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pelczynska M,Switalska M,Maciejewska M,Jaroszewicz I,Kutner A,Opolski A

    更新日期:2006-07-01 00:00:00

  • In vitro sensitivity to the liposomal preparation, DaunoXome in CLL.

    abstract::In order to determine the efficacy of liposomal encapsulated daunorubicin (DaunoXome; DNX) in chronic Iymphocytic leukaemia, the sensitivities of cells from 10 patients with this disease were assessed and compared with that of free drug using the MTT assay. There was a marked variation in effect between patients for b...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sargent JM,Elgie AW,Williamson CJ,Lewandowicz GM,Taylor CG

    更新日期:1999-07-01 00:00:00

  • Silencing Delta-like 1 Expression Induces Migratory Features in Pancreatic Cancer Cells Through Stimulation of Src and p38 Signalling Pathway.

    abstract:BACKGROUND/AIM:The prognosis of pancreatic cancer has not improved due to its migratory feature and refractory potential to chemo-resistance with absence of effective diagnosis. Despite continuous efforts, its underlying mechanisms of malignant nature remain ambiguous. The objective of this study was to investigate del...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14075

    authors: Lee J,Lee J,Kim DH,Kim JH

    更新日期:2020-03-01 00:00:00